Gen Z is breaking stereotypes, but there are still some worrying trends when it comes to substance abuse.
Articles on Drugs
Displaying 221 - 240 of 550 articles
People with alcohol or substance dependency already struggle to access mental health treatment, covid will only make this worse.
It’s hard to get an accurate picture of how the pandemic has influenced drug use, but initial data suggests treatment services are reporting increased demand.
Social media makes it easy to spread ‘fake news’.
Can’t make up your mind in the recreational cannabis referendum? You’re not alone, so here’s some tips from both sides of the debate to help you decide.
The voices of recreational cannabis users are curiously missing from the official debate about legalisation.
There are ingredients in your pills other than the one designed to treat your ailments. Those unnamed ingredients can alter how you respond to a medicine or even make you sick.
While many people said they drank more during the pandemic, others actually drank less, mainly because socialising at clubs, pubs and parties wasn’t possible.
Bolivia’s drug control strategy was once internationally applauded.
The head lice drug ivermectin is being touted as a coronavirus killer. But studies suggest it would need to be taken in mega-doses far higher than those currently used, with unknown side-effects.
With all the attention focussed on combating the spread of COVID-19 it’s easy to forget the other health challenges that could affect us all.
Conventional thinking on drugs, conflict and development isn’t working – here’s why.
Illicit and legitimate trade are closely connected, so how come one seems to be rising while the other has plunged?
With regular music festivals, people can more easily seek help or advice about drug and alcohol or mental health issues. But with drive-ins we need to be creative to minimise harms.
When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor’s office.
Kinases are cellular control switches. When they malfunction, they can cause cancer. The coronavirus hijacks these kinases to replicate, and cancer drugs that target them could fight COVID-19.
After firms add more women to their board, dangerous medical products are recalled more quickly.
Scanning through billions of chemicals to find a few potential drugs for treating COVID-19 requires computers that harness together thousands of processors.
New rules attempt to curb opioid-related deaths in Australia. These changes are a step in the right direction – but we need to tread carefully to avoid unintended consequences.
The Covid-19 pandemic has laid bare Europe’s vulnerability to drug-supply disruption. Still, it remains by far the world leader in pharmaceutical products.
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Senior Lecturer of Addiction, Edith Cowan University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor in Substance Use, Liverpool John Moores University
-
Associate Professor, National Drug Research Institute / enAble Institute, Curtin University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
-
Senior Lecturer in Criminology, Swansea University
-
Senior Lecturer in Chemistry, University of Birmingham
-
PhD Candidate, Royal Holloway, University of London
-
Lecturer, RMIT University
-
University of Sydney
-
Associate Professor in Pharmacy Practice, Kingston University